| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8226264 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 5 Pages |
Abstract
The use of supplemental antioxidant beta-carotene during RT was not associated with an increased risk of prostate cancer death or metastases. This study suggests a lack of harm from supplemental beta-carotene during RT for prostate cancer.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Danielle N. M.D., M.P.H., Julie L. Sc.D., Neil E. M.D., M.P.H., Howard D. Sc.D., M.P.H., John Michael M.D., M.P.H., Jing M.D., Ph.D., Meir J. M.D., Dr.P.H., Lorelei A. Sc.D., M.P.H.,